Literature DB >> 21459606

Bloodstream infection in heart transplant recipients: 12-year experience at a university hospital in Taiwan.

Ron-Bin Hsu1, Chung-I Chang, Chi-Tai Fang, Shan-Chwen Chang, Shoei-Shen Wang, Shu-Hsun Chu.   

Abstract

OBJECTIVE: Bloodstream infection (BSI) is a well-recognized problem and it affects 10-50% of solid organ transplant recipients. The purpose of this study was to assess the incidence and prognosis of BSI in heart transplant recipients at our hospital.
METHODS: The study is a retrospective chart review.
RESULTS: We diagnosed 101 episodes of BSI in 73 out of 306 heart transplant patients (24%) during the 12-year study period. BSI occurred at a median of 191 days (range 1-3376) after transplant and 50% occurred within 6 months after transplant. Most BSI episodes were nosocomial (73%), especially those occurring within the first month (94%). As far as pathogen was concerned, Gram-negative bacteria predominated (57%), followed by Gram-positive bacteria (34%), fungus (5%), anaerobics (2%), and cryptococcus (2%). Overall 30-day mortality rate was 30%. Death occurred in 36% (13/36) of the patients with early-onset BSI, 14% (2/14) of the patients with BSI in months 2-6, and 29% (15/51) of the patients with late-onset BSI. Mortality rate was over 50% in those patients with Pseudomonal infection, fungal infection, cryptococcal infection of central nervous system, lung infection, and severe sepsis. Compared to Western series, there was a high incidence of infections caused by Enterobacter species and Acinetobacter baumannii.
CONCLUSIONS: There was a high incidence of BSI after heart transplantation in Taiwan, especially infections caused by Enterobacter species and A. baumannii. Mortality was high in patients with infection caused by Pseudomonas, Candida, and Cryptococcus and in patients with severe sepsis.
Copyright © 2011 European Association for Cardio-Thoracic Surgery. Published by Elsevier B.V. All rights reserved.

Entities:  

Mesh:

Year:  2011        PMID: 21459606     DOI: 10.1016/j.ejcts.2011.02.033

Source DB:  PubMed          Journal:  Eur J Cardiothorac Surg        ISSN: 1010-7940            Impact factor:   4.191


  6 in total

1.  Sepsis in the severely immunocompromised patient.

Authors:  Andre C Kalil; Steven M Opal
Journal:  Curr Infect Dis Rep       Date:  2015-06       Impact factor: 3.725

Review 2.  Epidemiology and management of healthcare-associated bloodstream infections in non-neutropenic immunosuppressed patients: a review of the literature.

Authors:  Nursel Calik Basaran; Sibel Ascioglu
Journal:  Ther Adv Infect Dis       Date:  2017-10-17

3.  Bloodstream Infections among Solid Organ Transplant Recipients: Eight Years' Experience from a Turkish University Hospital.

Authors:  Ayşegül Yeşilkaya; Ozlem Kurt Azap; Melike Hamiyet Demirkaya; Mehtap Akçıl Ok; Hande Arslan; Aydıncan Akdur
Journal:  Balkan Med J       Date:  2013-09-01       Impact factor: 2.021

Review 4.  Diagnostic and therapeutic approach to infectious diseases in solid organ transplant recipients.

Authors:  Jean-François Timsit; Romain Sonneville; Andre C Kalil; Matteo Bassetti; Ricard Ferrer; Samir Jaber; Fanny Lanternier; Charles-Edouard Luyt; Flavia Machado; Malgorzata Mikulska; Laurent Papazian; Fréderic Pène; Garyphalia Poulakou; Claudio Viscoli; Michel Wolff; Lara Zafrani; Christian Van Delden
Journal:  Intensive Care Med       Date:  2019-03-25       Impact factor: 17.440

5.  Risk Factors and Outcome of Multidrug-Resistant Infections after Heart Transplant: A Contemporary Single Center Experience.

Authors:  Arta Karruli; Jacopo de Cristofaro; Roberto Andini; Domenico Iossa; Mariano Bernardo; Cristiano Amarelli; Irene Mattucci; Rosa Zampino; Raffaele Zarrilli; Emanuele Durante-Mangoni
Journal:  Microorganisms       Date:  2021-06-03

6.  Infectious complications following heart transplantation in the era of high-priority allocation and extracorporeal membrane oxygenation.

Authors:  Stéphanie Pons; Romain Sonneville; Lila Bouadma; Lenka Styfalova; Stéphane Ruckly; Mathilde Neuville; Aguila Radjou; Jordane Lebut; Marie-Pierre Dilly; Bruno Mourvillier; Richard Dorent; Patrick Nataf; Michel Wolff; Jean-François Timsit
Journal:  Ann Intensive Care       Date:  2019-01-25       Impact factor: 6.925

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.